ClinicalTrials.govpublic full text
PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY
breast neoplasms, breast cancer, palbociclib (pd-0332991), tamoxifen, goserelin, any menopausal status, hormone receptor positive, her2 negative, locally advanced, metastatic, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 907942
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.